Oct 24, 2025
111:95
For every 95 shares held, investors received 111. The price per share adjusted from $2270.00 to $1942.79.
The split itself did not change the total investment value.
EyeGene, Inc. (KRX:185490) operates in the Biotechnology industry.
EyeGene, Inc. company overviewEyeGene, Inc.'s most recent stock split was on October 24, 2025. It was a 111-for-95 forward split, so shareholders received 111 shares for every 95 they held.
EyeGene, Inc. (KRX:185490) has split its stock 3 times: a 1091-for-1000 split on May 13, 2021, a 6-for-5 split on June 28, 2021, and a 111-for-95 split on October 24, 2025.
EyeGene, Inc. has split its stock 3 times. This history records 3 forward splits between May 13, 2021 and October 24, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In EyeGene, Inc.'s 111-for-95 split on October 24, 2025, every 95 shares became 111 shares.
EyeGene, Inc. has not announced a new split in our records. Its most recent split was on October 24, 2025, 1 year ago. Companies announce splits in advance, and any new KRX:185490 split will appear on this page.
Already premium?